Drug Topics Newsletter

To view this email as a web page, click here.

PHARMACISTS' REPORT

Five Tech Best Practices

Maintain your security and efficiency with these tips.

FDA Approves Soliris (Eculizumab) for Neuromyelitis Optica Spectrum Disorder

Complement inhibitor is the first treatment for the rare autoimmune disorder.

Ready for a stronger role in the chain of care?

As patient needs place greater demands on PCPs, pharmacy is changing — and it means opportunities for new lines of service. Here’s a detailed step-by-step you can use to ready your pharmacy for the future!

Read this eBook now.

First Medical Cannabis Degree Launched by University of Maryland Pharmacy School

Medical cannabis is the subject of a new master's degree program at the University of Maryland School of Pharmacy.

Study Finds a Lack of Deprescribing is Harmful and Expensive

Studies indicate a lack of deprescribing is causing physical and fiscal pain to patients.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.